Murchinson’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Murchinson’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-166,906	Closed	-$1.05M	–	60
2022 Q4	$1.05M	Buy	166,906 +4,282	+3%	+$23.7K	0.14%	29
2022 Q3	$833K	Buy	+162,624	New	+$1.02M	0.24%	32

Murchinson's FSTX Position: Q1 2023 in Review

Murchinson sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 166,906 shares — an estimated $1.05M sold.

Murchinson first reported a position in FSTX in Q3 2022 and held it in 2 quarters. The position peaked at $1.05M in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Murchinson reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Murchinson sold 166,906 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.05M.
Murchinson first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Murchinson's F-star Therapeutics, Inc. Common Stock position peaked at $1.05M in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Murchinson's 13F filing for Q1 2023, filed 15 May 2023.